SMS: Substrate Modification Study in Patients Getting an Implantable Cardioverter Defibrillator (ICD)

PHASE4CompletedINTERVENTIONAL
Enrollment

116

Participants

Timeline

Start Date

May 31, 2002

Primary Completion Date

April 30, 2010

Study Completion Date

August 31, 2011

Conditions
Tachycardia, Ventricular
Interventions
PROCEDURE

ICD Ablation plus VT-ablation

ICD-Therapy for the treatment of unstable VT´s plus catheter ablation for substrate modification

DEVICE

ICD Therapy

ICD Therapy for the Treatment of unstable VT´s

Trial Locations (7)

8200

Skejby Skygehus, Aarhus

20099

Allgemeines Krankenhaus St. Georg, Hamburg

20251

Universitätsklinikum Hamburg-Eppendorf, Hamburg

44789

Berufsgenossenschaftliche Kliniken Bergmannsheil, Bochum

60590

Klinikum der J.W. Goethe Universität, Frankfurt

67063

Klinikum der Stadt Ludwigshafen am Rhein, Ludwigshafen

97616

Herz- und Gefäßklinik GmbH, Bad Neustadt / Saale

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Medtronic

INDUSTRY

lead

Medtronic Cardiac Rhythm and Heart Failure

INDUSTRY